Feb 19, 2024, 17:52
Marco Donia: Pan-cancer proteogenomics characterization of tumor immunity
Marco Donia, Associate Professor at National Center for Cancer Immune Therapy, Denmark, shared on LinkedIn:
”Pan-cancer proteogenomics characterization of tumor immunity.
Free access (Cell, Feb 14th 2024).
Highlights:
- Proteogenomics reveals seven immune subtypes spanning 10 cancer types,
- DNA alterations associate with immune subtypes and affect proteomic profiles,
- Kinase activation in immune subtypes suggests potential therapeutic targets,
- Digital pathology reveals infiltrating cells associated with immune subtypes.”
Source: Marco Donia/LinkedIn
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Nov 12, 2024, 23:10
Nov 12, 2024, 23:07
Nov 12, 2024, 22:58
Nov 12, 2024, 22:56
Nov 12, 2024, 22:50
Nov 12, 2024, 22:46
Nov 12, 2024, 22:43
Nov 12, 2024, 19:34